Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Prostate Cancer

  Free Subscription


Articles published in Invest Radiol

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    September 2025
  1. BACHL M, Skwierawska D, Hadler D, Schreiter H, et al
    Pros and Cons of High-Performance Gradient Enabled Short-TE Prostate DWI: A Prospective Study.
    Invest Radiol. 2025;60:592-601.
    PubMed     Abstract available


    June 2025
  2. SKWIERAWSKA D, Bickelhaupt S, Bachl M, Janka R, et al
    Relevance of Prostatic Fluid on the Apparent Diffusion Coefficient: An Inversion Recovery Diffusion-Weighted Imaging Investigation.
    Invest Radiol. 2025;60:357-368.
    PubMed     Abstract available


    July 2024
  3. ROEST C, Yakar D, Rener Sitar DI, Bosma JS, et al
    Multimodal AI Combining Clinical and Imaging Inputs Improves Prostate Cancer Detection.
    Invest Radiol. 2024 Jul 29. doi: 10.1097/RLI.0000000000001102.
    PubMed     Abstract available


    December 2023
  4. TENBERGEN CJA, Fortuin AS, van Asten JJA, Veltien A, et al
    The Potential of Iron Oxide Nanoparticle-Enhanced MRI at 7 T Compared With 3 T for Detecting Small Suspicious Lymph Nodes in Patients With Prostate Cancer.
    Invest Radiol. 2023 Dec 29. doi: 10.1097/RLI.0000000000001056.
    PubMed     Abstract available


    November 2023
  5. SCHILHAM MGM, Somford DM, Veltien A, Zamecnik P, et al
    Subnodal Correspondence of PSMA Expression and USPIO-MRI in Metastatic Pelvic Lymph Nodes in Prostate Cancer.
    Invest Radiol. 2023 Nov 17. doi: 10.1097/RLI.0000000000001046.
    PubMed     Abstract available


    October 2023
  6. LEMBERSKIY G, Chandarana H, Bruno M, Ginocchio LA, et al
    Feasibility of Accelerated Prostate Diffusion-Weighted Imaging on 0.55 T MRI Enabled With Random Matrix Theory Denoising.
    Invest Radiol. 2023;58:720-729.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.